Abingworth Clinical Co-Development 3 Feeder, L.P. — Form D
Abingworth Clinical Co-Development 3 Feeder, L.P. of WASHINGTON, DC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-06-25. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-06-25
- Form: D
- Accession: 0002070906-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.7
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-549753
Issuer
- Name: Abingworth Clinical Co-Development 3 Feeder, L.P.
- CIK: 0002070906
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2025
- Address: 1001 PENNSYLVANIA AVE., N.W., WASHINGTON, DC, 20004
- Phone: (202) 729-5626
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jeremy Anderson | Executive Officer | Washington, DC |
| Christina Gibbs | Executive Officer | Washington, DC |
| David Lobe | Executive Officer | Washington, DC |
| Robert Rosen | Executive Officer | Washington, DC |
| N/A ACCD 3 GP LP | Promoter | Washington, DC |
| N/A ACCD 3 Holdings, L.L.C. | Promoter | Washington, DC |
More